中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

134 records (took 0.026 seconds)

    노랑꽃창포 종자로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물
    3.
    发明公开
    노랑꽃창포 종자로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물 有权
    用于治疗包含从IRIS PSEUDACORUS的种子分离的RESVERATROL衍生物的癌症的药物组合物

    公开(公告)号：KR1020120119693A

    公开(公告)日：2012-10-31

    申请号：KR1020110037820

    申请日：2011-04-22

    Applicant: 한국화학연구원 ,  국민대학교산학협력단

    Inventor： 최상운 ,  최춘환 ,  유시용 ,  김영섭 ,  차미란 ,  김민진 ,  전정희 ,  김영균

    IPC: A61K31/343 ,  A61K36/882 ,  A61P35/00

    Abstract: PURPOSE: An anticancer drug composition which includes resveratrol derivative compound separated from iris tectorum seeds is provided to be used as therapeutic agent for various malign tumors. CONSTITUTION: An anticancer drug composition contains irisferin A, irisferin B, irisferin C, a pharmaceutically acceptable salt, isomer or a mixture thereof, or iris pseudacorus seed extract including the same as an active ingredient. The iris pseudacorus seed extract is obtained by extracting the iris pseudacorus seed with methanol, methanol aqueous solution, ethanol, ethanol water solution, butanol, dichloromethane, ethyl acetate or a mixture thereof. The cancer is lung cancer, ovarian cancer, melanoma, central nervous system cancer or colon carcinoma. A health supplement having the anti-cancer cell growth obstruction efficacy is irisferin A, irisferin B, irisferin C, a pharmaceutically acceptable salt, isomer or a mixture thereof, or iris pseudacorus seed extract including the same.

    Abstract translation: 目的：提供一种抗癌药物组合物，其中包括从虹膜花粉种子分离的白藜芦醇衍生物，用作各种恶性肿瘤的治疗剂。 构成：抗癌药物组合物含有虹膜蛋白A，虹膜蛋白B，虹膜蛋白C，其药学上可接受的盐，异构体或其混合物，或包含其作为活性成分的虹膜假科种子提取物。 通过用甲醇，甲醇水溶液，乙醇，乙醇水溶液，丁醇，二氯甲烷，乙酸乙酯或其混合物提取虹膜假科种获得虹膜假科种子提取物。 癌症是肺癌，卵巢癌，黑素瘤，中枢神经系统癌或结肠癌。 具有抗癌细胞生长阻塞功效的健康补充剂是虹膜蛋白A，虹膜蛋白B，虹膜蛋白C，其药学上可接受的盐，异构体或其混合物，或包含其的虹膜假科种子提取物。

    포도 줄기 껍질로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물
    4.
    发明公开
    포도 줄기 껍질로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물 审中-实审
    用于治疗包含来自葡萄膜干燥分离的抑制剂衍生物的癌症的药物组合物

    公开(公告)号：KR1020120116115A

    公开(公告)日：2012-10-22

    申请号：KR1020110033674

    申请日：2011-04-12

    Applicant: 한국화학연구원 ,  국민대학교산학협력단

    Inventor： 최상운 ,  유시용 ,  김영섭 ,  최춘환 ,  최연희 ,  차미란 ,  김영균

    IPC: A61K31/045 ,  A61K31/05 ,  A61K36/87 ,  A23L33/10 ,  A23L33/105 ,  A23L2/52

    CPC classification number: A61K31/045 ,  A23L2/52 ,  A23L33/10 ,  A23L33/105 ,  A61K31/05 ,  A61K36/87 ,  A61K2300/00

    Abstract: PURPOSE: An anticancer drug composition including resveratrol derivative compound separated from grape stem shell is provided to prevent and treat all kinds of cancers including lung cancer, ovarian cancer, melanoma, central nervous system tumor, colon carcinoma, and leukemia. CONSTITUTION: An anticancer drug composition includes vitisinol C, vitisinol E, cis-vitisin A, vitisin B, vitisin C, a pharmaceutically acceptable salt and isomer or a mixture thererof, and grape stem shell extract including thereof as an active ingredient. The grape stem shell extract is obtained by extracting methanol, methanol aqueous solution, ethanol, ethanol aqueous solution, butanol, dichloromethane, ethyl acetate or a mixture thereof. The cancer is lung cancer, ovarian cancer, melanoma or colon carcinoma. A health enhancement food having cancer cell growth inhibition efficacy contains vitisinol C, vitisinol E, cis-viticin A, viticin B, viticin C, pharmaceutically acceptable salt, isomer or a mixture thereof, and grapes stem shell extract including the same. The food is in beverage form. The grape stem shell extract is obtained by the following steps: extracting the grape stem shell by methanol and suspending the obtained extract in distilled water; partitioning thereof by dichloromethane; and extracting the obtained water layer by ethyl acetate.

    Abstract translation: 目的：提供包括从葡萄茎壳分离的白藜芦醇衍生物化合物的抗癌药物组合物，用于预防和治疗各种癌症，包括肺癌，卵巢癌，黑素瘤，中枢神经系统肿瘤，结肠癌和白血病。 构成：抗癌药物组合物包括维生素C，维生素E，顺式维生素A，维生素B，维生素C，其药学上可接受的盐和异构体或其混合物，以及包含它们的葡萄茎壳提取物作为活性成分。 葡萄茎壳提取物是通过提取甲醇，甲醇水溶液，乙醇，乙醇水溶液，丁醇，二氯甲烷，乙酸乙酯或其混合物得到的。 癌症是肺癌，卵巢癌，黑素瘤或结肠癌。 具有癌细胞生长抑制作用的健康增强食品包含维生素C，维生素E，顺式维生素A，维生素B，维生素C，其药学上可接受的盐，异构体或其混合物，以及包含其的葡萄茎壳提取物。 食物是饮料形式。 通过以下步骤获得葡萄茎壳提取物：用甲醇萃取葡萄茎壳，将得到的提取物悬浮于蒸馏水中; 用二氯甲烷分配; 并用乙酸乙酯萃取得到的水层。

    포도 줄기 껍질로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물
    5.
    发明授权
    포도 줄기 껍질로부터 분리된 레스베라트롤 유도체 화합물을 포함하는 항암제 조성물 有权
    包含从葡萄茎皮分离的白藜芦醇衍生物化合物的抗癌组合物

    公开(公告)号：KR101830222B1

    公开(公告)日：2018-02-22

    申请号：KR1020110033674

    申请日：2011-04-12

    Applicant: 한국화학연구원 ,  국민대학교산학협력단

    Inventor： 최상운 ,  유시용 ,  김영섭 ,  최춘환 ,  최연희 ,  차미란 ,  김영균

    IPC: A61K31/045 ,  A61K31/05 ,  A61K36/87 ,  A23L33/10 ,  A23L33/105 ,  A23L2/52

    Abstract: 본발명은포도() 줄기껍질추출물및 이로부터분리정제된레스베라트롤화합물인비티시놀 C(vitisinol C), 비티시놀 E(vitisinol E), 시스-비티신 A(cis-vitisin A), 비티신 B(vitisin B), 비티신 C(vitisin C) 및이들의혼합물로이루어진그룹으로부터선택된어느하나를약제학적으로허용되는담체와함께함유하는항암제조성물에관한것으로, 본발명의조성물은폐암, 난소암, 흑색종, 중추신경계종양, 결장암, 백혈병등 각종악성종양의예방및 치료제로사용될수 있다.

    Abstract translation: 本发明涉及干细胞树皮提取物和从其中分离出的白藜芦醇化合物，例如葡萄糖醇C，葡萄素醇E，顺式 - 葡萄素A， 葡萄干素B，葡萄干素C及其混合物以及药学上可接受的载体，其中本发明的组合物是包含肺癌，卵巢癌， 可用作癌症，中枢神经系统肿瘤，结肠癌和白血病等各种恶性肿瘤的预防和治疗剂。

    작약 종자 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 퇴행성 뇌질환 예방 또는 치료용 약학적 조성물
    7.
    发明公开
    작약 종자 추출물, 이의 분획물 또는 이로부터 분리한 화합물을 유효성분으로 함유하는 퇴행성 뇌질환 예방 또는 치료용 약학적 조성물 有权
    包含提取物的活性成分的药物组合物，其分离物或其分离的化合物作为活性成分

    公开(公告)号：KR1020120016861A

    公开(公告)日：2012-02-27

    申请号：KR1020100079356

    申请日：2010-08-17

    Applicant: 한국화학연구원

    Inventor： 김영섭 ,  유시용 ,  홍경식 ,  최춘환 ,  차미란 ,  박우규

    IPC: A61K36/65 ,  A61K31/343 ,  A61P25/28 ,  A61P25/00

    CPC classification number: A61K36/65 ,  A23L29/035 ,  A23V2200/322 ,  A61K31/216 ,  A61K31/343 ,  A61K2236/33

    Abstract: PURPOSE: A pharmaceutical composition containing Paeonia lactiflora seed extract, fraction thereof, or compound isolated from the same is provided to suppress BACE-1 activity and to treat and prevent neurodegenerative diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating neurodegenerative diseases contains Paeonia lactiflora seed extract as an active ingredient. The neurodegenerative diseases include Alzheimer's dieses, Parkinsons's disease, progressive supranuclear palsy. The extract is prepared using water, alcohol of C1-C4, or mixture solvent thereof. The pharmaceutical composition contains Paeonia lactiflora seed fraction as an active ingredient. The pharmaceutical composition also contains compounds as an active ingredient. The method for preparing the compounds comprises: a step of adding water, C1-C3 alcohol, or mixture thereof to the Paeonia lactiflora seeds to prepare Paeonia lactiflora seed extract; a step of fractioning the extract with water, dichloromethane, and ethyl acetate to prepare a fraction; a step of performing silicagel column chromatography of the fraction.

    Abstract translation: 目的：提供含有芍药提取物，其部分或从其分离的化合物的药物组合物以抑制BACE-1活性并治疗和预防神经变性疾病。 构成：用于预防或治疗神经变性疾病的药物组合物含有芍药种子提取物作为活性成分。 神经变性疾病包括阿尔茨海默氏病，帕金森氏病，进行性核上性麻痹。 萃取液用水，C1-C4的醇或其混合溶剂制备。 该药物组合物含有作为活性成分的芍药芍药种子。 药物组合物还含有作为活性成分的化合物。 制备化合物的方法包括：将水，C1-C3醇或其混合物加入到芍药种子中以制备芍药提取物的步骤; 用水，二氯甲烷和乙酸乙酯分级提取物以制备级分的步骤; 进行该级分的硅胶柱色谱的步骤。

    장생 도라지 추출물을 포함하는 허혈성 뇌혈관질환의 예방또는 개선용 조성물
    9.
    发明公开
    장생 도라지 추출물을 포함하는 허혈성 뇌혈관질환의 예방또는 개선용 조성물 无效
    用于防止或改善包含老式平板提取物的异构体损伤的组合物

    公开(公告)号：KR1020090067490A

    公开(公告)日：2009-06-25

    申请号：KR1020070135167

    申请日：2007-12-21

    Applicant: 한국화학연구원

    Inventor： 김영섭 ,  유시용 ,  연규환 ,  유대석 ,  최연희 ,  원무호 ,  황인구 ,  유기연

    IPC: A61K36/346 ,  A61P9/10

    Abstract: A pharmaceutical composition for preventing and treating ischemic cerebrovascular diseases, which contains old platycodon extract is provided to prevent the damage of nerve cell in the area of hippocampus anatomy and inhibit nerve cell apoptosis. A composition for preventing and treating ischemic cerebrovascular diseases comprises 0.1-90 weight% of Platycodon grandiflorum extract as an active ingredient. The ischemic cerebrovascular diseases are stroke, cerebral infarction, cerebral hemorrhage, subarachnoid hemorrhage, white matter dyslipidemia, brain hypoxia, alzheimer disease, parkinson's disease or Huntington disease. The Platycodon grandiflorum extract is obtained with water, C1-4 alcohol, ethylacetate, hexane or dichloromethane.

    Abstract translation: 提供含有老桔梗提取物的预防和治疗缺血性脑血管疾病的药物组合物，以防止神经细胞在海马解剖学领域的损伤并抑制神经细胞凋亡。 用于预防和治疗缺血性脑血管病的组合物含有0.1-90重量％的桔梗提取物作为活性成分。 缺血性脑血管病是中风，脑梗死，脑出血，蛛网膜下腔出血，白质血脂异常，脑缺氧，阿尔茨海默病，帕金森病或亨廷顿疾病。 用水，C 1-4醇，乙酸乙酯，己烷或二氯甲烷获得桔梗提取物。

    포도나무 수피로부터 분리된 ＢＡＣＥ-1 저해 효과를 갖는활성물질을 포함하는 퇴행성 뇌질환의 예방 또는 치료용조성물
    10.
    发明公开
    포도나무 수피로부터 분리된 ＢＡＣＥ-1 저해 효과를 갖는활성물질을 포함하는 퇴행성 뇌질환의 예방 또는 치료용조성물 有权
    用于预防或治疗包含活性成分的神经病变组合物，其从VITIS VINIFERA的标准分离，其对BACE-1具有抑制作用

    公开(公告)号：KR1020080025655A

    公开(公告)日：2008-03-21

    申请号：KR1020070095884

    申请日：2007-09-20

    Applicant: 한국화학연구원

    Inventor： 김영섭 ,  유시용 ,  연규환 ,  홍경식 ,  이병회 ,  유미영 ,  박우규

    IPC: A61K31/343 ,  A61K31/05 ,  A61P25/28

    Abstract: A composition comprising an extract of stembark of Vitis vinifera is provided to inhibit BACE-1(beta-site APP-cleaving enzyme 1) mediating formation of beta-amyloid, known to be a causing material of various dementia such as Alzheimer's disease, thereby being usefully used for preventing and treating neurodegenerative diseases such as senile dementia. A pharmaceutical composition for preventing or treating neurodegenerative diseases comprises a compound selected from the group consisting of vitisin A, epsilon-viniferin, ampelopsin A and a mixture thereof as an effective ingredient, wherein the compound is obtained by extracting stembark of Vitis vinifera with an organic solvent selected from the group consisting of C1-4 alcohol and an aqueous solution thereof, dichloromethane, ethyl acetate and a mixture thereof.

    Abstract translation: 提供了包含葡萄树葡萄树的提取物的组合物以抑制介导β-淀粉样蛋白形成的BACE-1（β-位点APP切割酶1），已知其是引起各种痴呆的物质，例如阿尔茨海默病，因此是 有用地用于预防和治疗老年性痴呆等神经变性疾病。 用于预防或治疗神经退行性疾病的药物组合物包括选自维生素A，ε-荧光素，安非他酮A及其混合物作为有效成分的化合物，其中所述化合物通过用有机物提取葡萄葡萄树 溶剂，其选自C1-4醇及其水溶液，二氯甲烷，乙酸乙酯及其混合物。

Patent Agency Ranking